[go: up one dir, main page]

ES2395679A1 - Método para la evaluación del comportamiento atlético de un sujeto. - Google Patents

Método para la evaluación del comportamiento atlético de un sujeto. Download PDF

Info

Publication number
ES2395679A1
ES2395679A1 ES201190077A ES201190077A ES2395679A1 ES 2395679 A1 ES2395679 A1 ES 2395679A1 ES 201190077 A ES201190077 A ES 201190077A ES 201190077 A ES201190077 A ES 201190077A ES 2395679 A1 ES2395679 A1 ES 2395679A1
Authority
ES
Spain
Prior art keywords
subject
evaluating
relates
athletic capabilities
athletic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES201190077A
Other languages
English (en)
Other versions
ES2395679B1 (es
Inventor
Laureano Simón Buela
Antonio Martínez Martínez
Diego Tejedor Hernández
Marta Artieda Oseñalde
Amaya BUXENS AZCOAGA
David ARTETA GARCÍA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Progenika Biopharma SA
Original Assignee
Progenika Biopharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Progenika Biopharma SA filed Critical Progenika Biopharma SA
Priority to ES201190077A priority Critical patent/ES2395679B1/es
Publication of ES2395679A1 publication Critical patent/ES2395679A1/es
Application granted granted Critical
Publication of ES2395679B1 publication Critical patent/ES2395679B1/es
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Método para la evaluación del comportamiento atlético de un sujeto.La presente invención describe un método de predicción del potencial de un sujeto hacia deportes de potencia o de resistencia, basado en el genotipado de marcadores polimórficos de determinados genes asociados con eventos deportivos. Asimismo, también describe un ADN-chip que comprende sondas específicas para los polimorfismos a detectar y un kit con el cual se puede llevar a cabo el método de la invención. Dicho modelo predictivo se puede utilizar para personalizar los programas de entrenamiento de los deportistas.
ES201190077A 2009-06-17 2010-06-16 Método para la evaluación del comportamiento atlético de un sujeto. Expired - Fee Related ES2395679B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES201190077A ES2395679B1 (es) 2009-06-17 2010-06-16 Método para la evaluación del comportamiento atlético de un sujeto.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ES200901439 2009-06-17
ES200901439 2009-06-17
PCT/ES2010/070402 WO2010146214A2 (es) 2009-06-17 2010-06-16 Método para la evaluación del comportamiento atlético de un sujeto
ES201190077A ES2395679B1 (es) 2009-06-17 2010-06-16 Método para la evaluación del comportamiento atlético de un sujeto.

Publications (2)

Publication Number Publication Date
ES2395679A1 true ES2395679A1 (es) 2013-02-14
ES2395679B1 ES2395679B1 (es) 2013-10-23

Family

ID=42705356

Family Applications (1)

Application Number Title Priority Date Filing Date
ES201190077A Expired - Fee Related ES2395679B1 (es) 2009-06-17 2010-06-16 Método para la evaluación del comportamiento atlético de un sujeto.

Country Status (2)

Country Link
ES (1) ES2395679B1 (es)
WO (1) WO2010146214A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106086222A (zh) * 2016-08-24 2016-11-09 厦门美因生物科技有限公司 基于qPCR分型技术的运动基因检测评估方法及系统
CN109468388A (zh) * 2018-12-25 2019-03-15 北京北基医学检验实验室有限公司 一种扩增与运动能力相关基因的引物组及检测试剂盒
SG10201905438RA (en) * 2019-06-14 2021-01-28 Hui Qi Low System and method for conducting trait assessment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024947A1 (en) * 2002-09-16 2004-03-25 Genetic Technologies Limited Actn3 genotype screen for athletic performance
WO2008102038A2 (es) * 2007-02-23 2008-08-28 Progenika Biopharma, S.A. Método y producto para genotipado “in vitro” con aplicación en medicina anti-envejecimiento

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004024947A1 (en) * 2002-09-16 2004-03-25 Genetic Technologies Limited Actn3 genotype screen for athletic performance
WO2008102038A2 (es) * 2007-02-23 2008-08-28 Progenika Biopharma, S.A. Método y producto para genotipado “in vitro” con aplicación en medicina anti-envejecimiento

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
2007, WOLFARTH B. et al. Association between a b2-adrenergic receptor polymorphism and elite endurance performance. Metabolism, Clinical and Experimental. 2007. Vol. 56, páginas: 1649-1651, página 1649, resumen. *

Also Published As

Publication number Publication date
WO2010146214A3 (es) 2011-06-30
ES2395679B1 (es) 2013-10-23
WO2010146214A2 (es) 2010-12-23

Similar Documents

Publication Publication Date Title
MacMahon et al. Knowledge base as a mechanism for perceptual-cognitive tasks: Skill is in the details!
WO2009140569A3 (en) Genetic markers for weight management and methods of use thereof
WO2011063098A3 (en) Genetic markers for weight management and methods of use thereof
ATE488602T1 (de) Actn3-genotyp-screen für athletische leistung
EP2146784A4 (en) SPORTSBALL WITH REINFORCED SEA SHARPNESS
AU2008304205A8 (en) Methods and systems for genomic analysis using ancestral data
FR2926375B1 (fr) Procede d'execution d'une application informatique, kit et aeronef associes
EP2310525A4 (en) ASSOCIATED GENETIC POLYMORPHISMS ASSOCIATED WITH CARDIOVASCULAR DISEASES, DETECTION METHODS AND THEIR USE
EP2349002A4 (en) METHOD AND DEVICE FOR ASSESSING, TRAINING AND IMPROVING THE PERCEPTUAL COGNITIVE SKILLS OF ONE PERSON
FI20085402A0 (fi) Kuntotesti
NZ596070A (en) Genetic variants contributing to risk of prostate cancer
WO2008144761A3 (en) Methods and compositions for identifying and treating lupus
NZ589251A (en) Novel marker for detection of bladder cancer
WO2010092164A3 (en) Bacterial dna as markers of cardiovascular and/or metabolic disease
BR112012009144B8 (pt) rostafuroxina, método para a identificação de um indivíduo com melhor resposta à rostafuroxina e kit de partes para avaliar o tratamento de rostafuroxina para um indivíduo
WO2012056451A3 (en) Peripheral blood gene markers for early diagnosis of parkinson's disease
WO2010030171A8 (en) Method for diagnostic marker development
BRPI0912591A2 (pt) "planta, semente de planta, método de alteração de arquitetura de raiz em uma planta, método de avaliação de alteração de arquitetura de raiz em uma planta, método de determinação de uma alteração de pelo menos uma característica agronômica em uma planta, polinucleotídeo isolado e planta ou semente"
EP2208795A4 (en) NUCLEIC ACID DETECTION METHOD AND NUCLEIC ACID DETERGENT KIT
ES2395679A1 (es) Método para la evaluación del comportamiento atlético de un sujeto.
NO20090993L (no) BIQ-markorer for vurdering av leverfunksjon
ATE551102T1 (de) Übungshilfe für das putten
IT1391496B1 (it) Costume natatorio per allenamento in sport acquatici.
WO2012024189A3 (en) Compositions and methods for determining predisposition to developing metabolic syndrome
Drozdovs' ka et al. T (-786)--> C-polymorphism of the endothelial nitric oxide synthase promoter gene (eNOS) and exercise performance in sport

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 2395679

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20131023

FD2A Announcement of lapse in spain

Effective date: 20210915